Exchange: NASDAQ·Updated 09:30 AM EDT

AFMDAffimed N.V.

$0.0001
$0.00
(0.00%)
Today
Reported EarningsNov 14
Mkt Cap$1,523.00
Vol1,199.00
News
all
press releases
News Placeholder
Compugen (CGEN) Reports Q1 Loss, Misses Revenue Estimates
Zacks
News Placeholder
Mersana Therapeutics, Inc. (MRSN) Reports Q1 Loss, Lags Revenue Estimates
Zacks
News Placeholder
MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Misses Revenue Estimates
Zacks
News Placeholder
Affimed Receives Nasdaq Deficiency Notice Over Low Share Price: Retail’s In Wait-And-Wait Mode
The company has been granted an initial period of 180 calendar days, or until October 13, 2025, to regain compliance with Nasdaq’s Minimum Bid Price Rule.
Stocktwits
<
...
1
>

Advertisement|Remove ads.